 Elizabeth Humes
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 21 | 2024 | 2837 | 1.420 |
Why?
| | Transgender Persons | 6 | 2024 | 186 | 0.980 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 2023 | 230 | 0.520 |
Why?
| | Sexual and Gender Minorities | 3 | 2024 | 215 | 0.450 |
Why?
| | Gonorrhea | 2 | 2021 | 59 | 0.310 |
Why?
| | Anti-HIV Agents | 2 | 2022 | 778 | 0.230 |
Why?
| | Cohort Studies | 9 | 2024 | 5750 | 0.210 |
Why?
| | HIV Seropositivity | 1 | 2023 | 125 | 0.190 |
Why?
| | Dyslipidemias | 1 | 2024 | 176 | 0.190 |
Why?
| | Psychosurgery | 1 | 2021 | 8 | 0.180 |
Why?
| | United States | 12 | 2024 | 14870 | 0.180 |
Why?
| | Coinfection | 1 | 2022 | 137 | 0.180 |
Why?
| | Epidemics | 1 | 2022 | 89 | 0.170 |
Why?
| | Homosexuality, Male | 4 | 2024 | 184 | 0.170 |
Why?
| | Chlamydia Infections | 1 | 2021 | 75 | 0.160 |
Why?
| | Drug Resistant Epilepsy | 1 | 2021 | 102 | 0.160 |
Why?
| | Laser Therapy | 1 | 2021 | 130 | 0.160 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 91 | 0.160 |
Why?
| | Crime Victims | 1 | 2021 | 128 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 130 | 0.160 |
Why?
| | Hepatitis C | 1 | 2022 | 271 | 0.160 |
Why?
| | Life Expectancy | 1 | 2019 | 69 | 0.160 |
Why?
| | Sexually Transmitted Diseases | 1 | 2021 | 161 | 0.150 |
Why?
| | Syphilis | 1 | 2019 | 32 | 0.150 |
Why?
| | Quality Control | 1 | 2019 | 172 | 0.150 |
Why?
| | Age Distribution | 3 | 2023 | 392 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 617 | 0.130 |
Why?
| | CD4 Lymphocyte Count | 3 | 2022 | 269 | 0.130 |
Why?
| | Incidence | 5 | 2024 | 2804 | 0.130 |
Why?
| | Male | 18 | 2024 | 67906 | 0.130 |
Why?
| | Adult | 14 | 2024 | 38023 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2019 | 578 | 0.120 |
Why?
| | Risk Factors | 7 | 2024 | 10407 | 0.120 |
Why?
| | Food Microbiology | 1 | 2015 | 66 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2024 | 1041 | 0.120 |
Why?
| | Humans | 25 | 2024 | 137782 | 0.120 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1047 | 0.120 |
Why?
| | Hypertension | 1 | 2024 | 1298 | 0.110 |
Why?
| | Foodborne Diseases | 1 | 2015 | 57 | 0.110 |
Why?
| | Meiosis | 1 | 2013 | 82 | 0.100 |
Why?
| | Female | 15 | 2024 | 73465 | 0.100 |
Why?
| | DNA Transposable Elements | 1 | 2013 | 121 | 0.100 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 92 | 0.090 |
Why?
| | Prescriptions | 2 | 2022 | 67 | 0.090 |
Why?
| | Nucleosomes | 1 | 2013 | 155 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1070 | 0.090 |
Why?
| | Substance-Related Disorders | 1 | 2019 | 1083 | 0.090 |
Why?
| | Baltimore | 2 | 2021 | 60 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2111 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2673 | 0.070 |
Why?
| | Young Adult | 5 | 2024 | 13240 | 0.070 |
Why?
| | Middle Aged | 7 | 2023 | 33554 | 0.070 |
Why?
| | Public Health Surveillance | 2 | 2019 | 82 | 0.070 |
Why?
| | Live Birth | 1 | 2006 | 66 | 0.060 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2006 | 52 | 0.060 |
Why?
| | Sexual Behavior | 2 | 2021 | 485 | 0.060 |
Why?
| | Pregnancy Trimester, First | 1 | 2006 | 140 | 0.060 |
Why?
| | Prevalence | 2 | 2024 | 2734 | 0.060 |
Why?
| | Adolescent | 5 | 2024 | 21574 | 0.060 |
Why?
| | Southeastern United States | 1 | 2024 | 32 | 0.060 |
Why?
| | Aged | 5 | 2022 | 24001 | 0.060 |
Why?
| | Quinazolines | 1 | 2006 | 251 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2534 | 0.060 |
Why?
| | Multimorbidity | 1 | 2024 | 47 | 0.050 |
Why?
| | Population Density | 1 | 2023 | 95 | 0.050 |
Why?
| | Food Supply | 1 | 2024 | 83 | 0.050 |
Why?
| | Social Stigma | 1 | 2024 | 138 | 0.050 |
Why?
| | Housing | 1 | 2024 | 146 | 0.050 |
Why?
| | Aging | 2 | 2023 | 1865 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2022 | 91 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2021 | 71 | 0.040 |
Why?
| | Hepacivirus | 1 | 2022 | 261 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 624 | 0.040 |
Why?
| | HIV | 1 | 2021 | 234 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 521 | 0.040 |
Why?
| | Internet | 1 | 2024 | 655 | 0.040 |
Why?
| | Viral Load | 1 | 2022 | 469 | 0.040 |
Why?
| | Prospective Studies | 2 | 2022 | 7623 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2021 | 271 | 0.040 |
Why?
| | Anti-Retroviral Agents | 1 | 2022 | 233 | 0.040 |
Why?
| | Heterosexuality | 1 | 2019 | 43 | 0.040 |
Why?
| | Cause of Death | 1 | 2021 | 436 | 0.040 |
Why?
| | Computer Simulation | 1 | 2023 | 982 | 0.040 |
Why?
| | North America | 1 | 2019 | 313 | 0.040 |
Why?
| | Comorbidity | 1 | 2024 | 1623 | 0.040 |
Why?
| | Population Surveillance | 1 | 2021 | 482 | 0.030 |
Why?
| | Sexual Partners | 1 | 2019 | 186 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 744 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 479 | 0.030 |
Why?
| | Shiga Toxins | 1 | 2015 | 3 | 0.030 |
Why?
| | Connecticut | 1 | 2015 | 27 | 0.030 |
Why?
| | Escherichia coli O157 | 1 | 2015 | 31 | 0.030 |
Why?
| | Infant | 2 | 2022 | 9482 | 0.030 |
Why?
| | Communicable Diseases, Emerging | 1 | 2015 | 36 | 0.030 |
Why?
| | Salmonella | 1 | 2015 | 62 | 0.030 |
Why?
| | Community Networks | 1 | 2015 | 58 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2006 | 2253 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3290 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 2013 | 65 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2013 | 123 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1288 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 523 | 0.020 |
Why?
| | DNA Repair | 1 | 2013 | 231 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 622 | 0.020 |
Why?
| | Genome | 1 | 2013 | 300 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1290 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2015 | 6084 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 443 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5793 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7637 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10837 | 0.020 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2006 | 83 | 0.020 |
Why?
| | Phenotype | 1 | 2013 | 3196 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2006 | 658 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 15682 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11105 | 0.010 |
Why?
| | Child | 1 | 2015 | 21989 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2129 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 6771 | 0.010 |
Why?
|
|
Humes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|